ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681639 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681639; 2) Community: the network communities that were significantly associated with the response to NSC 681639; 3) Molecule: the relationships between components within communities and NSC 681639; 4) MDR: the compounds that were significantly associated with the NSC 681639.

NSC Compound Enrichment Correlation
NSC 633781 1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate 0.00845932736945076 0.26816479
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.00845932736945076 0.46438431
NSC 646604 Null 0.00845932736945076 0.17147792
NSC 683557 Camptothecin Derivative 0.00845932736945082 0.83089549
NSC 706744 Indenoisoquinoline derivative 0.00845932736945082 0.83163091
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.00845932736945082 0.71001943
NSC 736567 Null 0.00845932736945082 0.35542127
NSC 744449 Null 0.00845932736945082 -0.077481007
NSC 109834 Null 0.00970780973624031 0.20383185
NSC 121713 Null 0.00970780973624031 0.22991126
Total:56  Current:13    [First] [Prev] [Next] [Last]